Hallucinations (DBCOND0003722)

Identifiers

Synonyms

Hallucination / Hallucinations, unspecified / Hallucinations (finding) / Hallucination NOS / Hallucinating

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Pimavanserin	A second generation atypical antipsychotic used for the treatment of hallucinations and delusions caused by Parkinson's Disease.	5-hydroxytryptamine receptor 2Atarget 5-hydroxytryptamine receptor 2Ctarget Sigma non-opioid intracellular receptor 1target Cytochrome P450 3A4enzyme Cytochrome P450 3A5enzyme Cytochrome P450 2J2enzyme Cytochrome P450 2D6enzyme
Sulpiride	A selective D2 dopamine receptor antagonist indicated to treat chronic and acute schizophrenia.	D(2) dopamine receptortarget D(3) dopamine receptortarget Cholinesteraseenzyme Carbonic anhydrase 2target Carbonic anhydrase 3target Albumincarrier Solute carrier family 22 member 1transporter Solute carrier family 22 member 2transporter Multidrug and toxin extrusion protein 1transporter Multidrug and toxin extrusion protein 2transporter D(4) dopamine receptortarget Solute carrier family 22 member 3transporter ATP-dependent translocase ABCB1transporter Broad substrate specificity ATP-binding cassette transporter ABCG2transporter

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00328952	Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia	No drug interventions	Not Available	Not Available	completed
NCT04399096	Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experience of Hallucinations	No drug interventions	Not Available	Not Available	unknown_status
NCT05240339	Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD)	No drug interventions	Not Available	Not Available	completed
NCT01907568	Understanding Hallucinations (Part I)	No drug interventions	Not Available	Not Available	unknown_status
NCT04352569	Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia	No drug interventions	treatment	Not Available	recruiting
NCT04990414	Cognitive Behaviour Therapy for Voices and Dissociation	No drug interventions	treatment	2	completed
NCT00308997	Transcranial Magnetic Stimulation for "Voices"	No drug interventions	treatment	2	completed
NCT03807388	ReMindCare App for Patients From First Episode of Psychosis Unit.	No drug interventions	treatment	Not Available	unknown_status
NCT00701909	Pain Medicine for Wound Care Procedures	Ketamine Morphine	treatment	3	completed
NCT02974400	Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With Psychosis	No drug interventions	treatment	Not Available	completed
NCT00042159	Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations	No drug interventions	treatment	Not Available	completed
NCT00087542	Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug	Pimavanserin	treatment	2	completed
NCT01373866	Multimodal MRI-guided rTMS to Treat Refractory Hallucinations	No drug interventions	treatment	Not Available	completed
NCT02460965	Understanding Hallucinations (Part II)	No drug interventions	Not Available	Not Available	unknown_status
NCT06208176	HD-tDCS for Hallucinations	No drug interventions	treatment	Not Available	not_yet_recruiting
NCT05210062	Impact of Closely Grouped, Iterative Exposures to Suxamethonium During ECT on the Sensitization to NMBA and the Development of Protective Antibodies	No drug interventions	Not Available	Not Available	unknown_status
NCT00288340	Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging	No drug interventions	treatment	Not Available	completed